Hims & Hers Health (NYSE:HIMS) Shares Gap Up to $11.26

Hims & Hers Health, Inc. (NYSE:HIMS)’s share price gapped up before the market opened on Monday . The stock had previously closed at $11.26, but opened at $11.80. Hims & Hers Health shares last traded at $11.68, with a volume of 3,705,664 shares traded.

Analyst Upgrades and Downgrades

Several equities analysts have commented on HIMS shares. Jefferies Financial Group reissued a “hold” rating and set a $15.00 target price (down previously from $17.00) on shares of Hims & Hers Health in a research report on Tuesday, April 16th. Seaport Res Ptn reaffirmed a “buy” rating on shares of Hims & Hers Health in a research report on Friday, April 26th. Leerink Partnrs reaffirmed a “market perform” rating on shares of Hims & Hers Health in a research report on Monday, February 26th. Piper Sandler raised their price target on Hims & Hers Health from $9.00 to $11.00 and gave the stock a “neutral” rating in a report on Tuesday, February 27th. Finally, TheStreet upgraded Hims & Hers Health from a “d” rating to a “c” rating in a research report on Monday, March 4th. Five analysts have rated the stock with a hold rating and nine have issued a buy rating to the stock. According to data from MarketBeat.com, Hims & Hers Health presently has a consensus rating of “Moderate Buy” and a consensus target price of $14.85.

Hims & Hers Health Trading Up 3.5 %

The stock’s fifty day moving average price is $14.01 and its two-hundred day moving average price is $10.31. The stock has a market capitalization of $2.50 billion, a P/E ratio of -106.82 and a beta of 0.97.

Hims & Hers Health (NYSE:HIMS) last issued its quarterly earnings data on Monday, February 26th. The company reported $0.01 EPS for the quarter, beating the consensus estimate of ($0.02) by $0.03. The firm had revenue of $246.60 million during the quarter, compared to the consensus estimate of $245.84 million. Hims & Hers Health had a negative net margin of 2.70% and a negative return on equity of 7.21%. The company’s quarterly revenue was up 47.4% compared to the same quarter last year. During the same period in the prior year, the firm posted ($0.05) earnings per share. As a group, analysts expect that Hims & Hers Health, Inc. will post 0.11 earnings per share for the current fiscal year.

Insider Buying and Selling

In other news, insider Soleil Boughton sold 4,080 shares of the business’s stock in a transaction on Friday, February 9th. The stock was sold at an average price of $10.03, for a total value of $40,922.40. Following the completion of the transaction, the insider now owns 154,345 shares in the company, valued at $1,548,080.35. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. In other news, insider Soleil Boughton sold 4,080 shares of the stock in a transaction on Friday, February 9th. The stock was sold at an average price of $10.03, for a total transaction of $40,922.40. Following the transaction, the insider now directly owns 154,345 shares of the company’s stock, valued at approximately $1,548,080.35. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, COO Melissa Baird sold 11,750 shares of the firm’s stock in a transaction dated Thursday, May 2nd. The stock was sold at an average price of $12.08, for a total value of $141,940.00. Following the completion of the transaction, the chief operating officer now directly owns 538,932 shares in the company, valued at $6,510,298.56. The disclosure for this sale can be found here. Insiders have sold a total of 736,191 shares of company stock worth $9,733,700 in the last quarter. Corporate insiders own 31.63% of the company’s stock.

Institutional Trading of Hims & Hers Health

Several institutional investors have recently modified their holdings of HIMS. GSA Capital Partners LLP boosted its stake in shares of Hims & Hers Health by 160.5% in the first quarter. GSA Capital Partners LLP now owns 210,965 shares of the company’s stock worth $3,264,000 after acquiring an additional 129,993 shares during the last quarter. Oak Ridge Investments LLC purchased a new position in Hims & Hers Health in the 1st quarter valued at $2,066,000. Diversify Advisory Services LLC acquired a new stake in Hims & Hers Health during the 1st quarter worth $701,000. Principal Financial Group Inc. grew its holdings in shares of Hims & Hers Health by 17.9% during the first quarter. Principal Financial Group Inc. now owns 16,655 shares of the company’s stock worth $258,000 after buying an additional 2,525 shares in the last quarter. Finally, Cornerstone Investment Partners LLC purchased a new position in shares of Hims & Hers Health in the first quarter worth about $161,000. Institutional investors and hedge funds own 63.52% of the company’s stock.

Hims & Hers Health Company Profile

Hims & Hers Health, Inc operates a telehealth platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, and internationally. The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by customers.